Article
GBMPurity: A machine learning tool for estimating glioblastoma tumor purity from bulk RNA-sequencing data
31 Jan 2025
Abstract excerpt
BACKGROUND: Glioblastoma (GBM) presents a significant clinical challenge due to its aggressive nature and extensive heterogeneity. Tumor purity, the proportion of malignant cells within a tumor, is an important covariate for understanding the disease, having direct clinical relevance or obscuring signal of the malignant portion in molecular analyses of bulk samples. However, current methods for estimating tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
